Endocarditis prophylaxis regimens for dental procedures

Antibiotic prophylaxis regimens

If, after careful evaluation of both the cardiac condition (see here) and the dental procedure (see here), antibiotic prophylaxis is considered necessary, give a single dose of antibiotic before the procedure. There is no proven value to giving a dose after the procedure.

If a patient is having more than one procedure requiring antibiotic prophylaxis, the dentist should plan the treatment so that all procedures can be completed in a single sitting, or at most two sittings, to avoid the need for multiple antibiotic doses.

For endocarditis prophylaxis, use:

amoxicillin 2 g (child: 50 mg/kg up to 2 g) orally, 60 minutes before the procedure. endocarditis prophylaxis, dental procedures amoxicillin amoxicillin amoxicillin

If oral administration is not possible, use:

1 amoxicillin 2 g (child: 50 mg/kg up to 2 g) intramuscularly, 30 minutes before the procedure amoxicillin amoxicillin amoxicillin

OR

1 amoxicillin 2 g (child: 50 mg/kg up to 2 g) intravenously, within the 60 minutes before the procedure amoxicillin amoxicillin amoxicillin

OR

1 ampicillin 2 g (child: 50 mg/kg up to 2 g) intramuscularly, 30 minutes before the procedure endocarditis prophylaxis, dental procedures ampicillin    

OR

1 ampicillin 2 g (child: 50 mg/kg up to 2 g) intravenously, within the 60 minutes before the procedure. ampicillin    

For patients with delayed nonsevere hypersensitivity to penicillins, cefalexin can be used in most cases1. Use:

cefalexin 2 g (child: 50 mg/kg up to 2 g) orally, 60 minutes before the procedure. endocarditis prophylaxis, dental procedures cefalexin    

If oral administration is not possible, use:

1 cefazolin 2 g (child: 30 mg/kg up to 2 g) intramuscularly, 30 minutes before the procedure endocarditis prophylaxis, dental procedures cefazolin    

OR

1 cefazolin 2 g (child: 30 mg/kg up to 2 g) intravenously, within the 60 minutes before the procedure. cefazolin    

For patients with immediate (severe or nonsevere) or delayed severe hypersensitivity to penicillins, use:

clindamycin 600 mg (child: 20 mg/kg up to 600 mg) orally, 60 to 120 minutes before the procedure2. endocarditis prophylaxis, dental procedures clindamycin    

If oral administration is not possible, use:

clindamycin 600 mg (child: 20 mg/kg up to 600 mg) intravenously, within the 120 minutes before the procedure. clindamycin    

There is some evidence that moxifloxacin may be used as an alternative to clindamycin for patients with immediate (severe or nonsevere) or delayed severe hypersensitivity to penicillins, but this has not been validated.

Considerations for patients recently or currently taking beta lactams

In patients taking long-term benzathine benzylpenicillin for prevention of recurrent rheumatic fever, evidence suggests that the amoxicillin susceptibility of viridans streptococci in the oral flora is not significantly affected by the benzathine benzylpenicillin prophylaxis. The consensus view of the Antibiotic Expert Groups is that amoxicillin is appropriate for endocarditis prophylaxis in this setting.

In contrast, in patients currently taking or who have recently taken a course of beta-lactam therapy (except for the situation described above), evidence suggests that the amoxicillin susceptibility of viridans streptococci may be affected. Therefore, a non–beta-lactam antibiotic, such as clindamycin, may be considered for prophylaxis in this setting.

1 It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity.Return
2 An oral liquid formulation of clindamycin is not commercially available; for formulation options for children or people with swallowing difficulties, see the Don’t Rush to Crush Handbook, published by the Society of Hospital Pharmacists of Australia [URL]. Return